A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 414 participants.
Also called NCT02268929
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 414 participants
- Registry
-
NCT02268929
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT02268929. Randomized; no masking; primary purpose diagnostic. Start 2014-10-14 (actual); primary completion 2017-01-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.
- Acronym
- PDM-ProValueGP
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Device)
- Accu-Chek Smart Pix Software
- Intervention (Device)
- Accu-Chek Smart Pix readout Device
- Lead sponsor
- Hoffmann-La Roche
- Collaborator
- Roche Diabetes Care
Record details
- Record id
cardio:ct-nct02268929- Content hash
4e97994afd71e8a318d89216cee01c6bc25a818cddec659393f63e0e39c4c1d5